CLAIM #11991 · Bristol-Myers Squibb Company (BMY) · 2024Q2 earnings call · Jul 26, 2024 · due Dec 31, 2026
“Certainly, both trials have moved to the Part 2 of the study and you will continue to hear about how the trial progresses and we're looking forward to the readout starting in 2026.”
Samit Hirawat · Chief Medical Officer
PENDING
graded after results covering Dec 31, 2026 are reported
How to check this claim
Look at: Public disclosure of Part 2 trial readout/data (topline or detailed results) for the two referenced studies
It came true if: At least one of the two trials reports readout data on or before 2026-12-31
Where: Company press release, clinical trial results disclosure (e.g., clinicaltrials.gov posting, medical conference presentation, or earnings call commentary)
Verify independently
SEC filings for BMY ↗ · Claim quote is verbatim from the 2024Q2 earnings call.